Aim: Limited epidemiological studies have investigated the relationship between ischemic vascular disease and periodontitis in non-Western populations. We investigated this relationship in a Japanese cohort by measuring serum titers of antibodies to periodontopathic bacteria. Methods: As part of the Tokamachi-Nakasato cohort study, we followed up 7021 participants regarding cardiovascular events over 5 years, and observed 99 ischemic vascular events: 66 cerebral infarctions and 33 cases of ischemic heart disease (IHD). For a nested case-control study, we selected 495 sex-and age-matched control subjects. Conditional logistic regression analysis was used to estimate the odds ratios (OR) and 95% confidence intervals (CI) of ischemic vascular events associated with antibody titers to Porphyromonas gingivalis FDC381 and SU63. Multivariable models were adjusted for traditional cardiovascular risk factors using propensity scores. Results: The highest tertile category of antibody titers to P. gingivalis FDC381 in men was significantly associated with an increased risk of cerebral infarction in only the crude model. The 2nd and 3rd tertile categories of antibody titers to P. gingivalis SU63 were significantly associated with an increased risk of cerebral infarction in men (multivariable ORs (95% CIs) were 7.12 (1.51-33.5) and 9.03 (1.97-41.5), respectively). The association was not appreciably modified when we further adjusted for serum high-sensitivity C-reactive protein levels. Antibody titers to P. gingivalis were not dose-dependently associated with the risk of IHD. Conclusion: High serum antibody titers to P. gingivalis SU63 could be a predictor of cerebral infarction in Japanese men independent of traditional risk factors and inflammation. J Atheroscler Thromb, 2011; 18:808-817.
Introduction
Several studies have suggested chronic periodontitis as a possible risk factor for ischemic vascular disease, such as cerebral infarction and ischemic heart disease (IHD) [1] [2] [3] [4] sociation between elevated antibody titers against common pathogens, such as Chlamydia pneumoniae and Helicobacter pylori, and sustained chronic infections or risk of mortality from coronary heart disease [5] [6] [7] [8] . Hence, a bacterial burden in gingival tissues that is sufficient to induce systemic inflammation may modulate atherogenesis and inflammation of vascular walls 9) in periodontitis patients 10) . Indeed, several studies have confirmed the relationship between periodontal tissue destruction in periodontitis patients and serum C-reactive protein (CRP) levels 11, 12) . Porphyromonas gingivalis, a periodontopathic Gram-negative bacterium, has been extensively analyzed with regard to its role in the pathogenesis of atherogenesis [13] [14] [15] [16] [17] . A high frequency of antibody positivity for P. gingivalis SU63 was observed in patients with IHD, suggesting an association between the presence of a particular highly virulent strain and IHD 18) . Previous reports have demonstrated an association between antibody titers to Aggregatibacter actinomycetemcomitans and P. gingivalis and the incidence of stroke 4) and IHD 19, 20) in a Western population. A recent nested case-control study in a larger cohort demonstrated the influence of systemic exposure to P. gingivalis on the incidence of stroke 21) . No studies to date have investigated the association between ischemic vascular disease and periodontitis in an Asian population using a nested case-control model. Differing genetic backgrounds and lifestyles among populations may affect the incidence of ischemic vascular disease in patients. The aim of our research was to investigate the association between serum antibody levels to P. gingivalis strains FDC381 and SU63 and ischemic vascular disease in a Japanese population using a nested case-control study.
Materials and Methods

Study subjects and outcome
We designed a nested case-control study as a part of the Tokamachi-Nakasato cohort study 22) . The study areas were Tokamachi City and its neighboring village, Nakasato, Niigata Prefecture, Japan. According to the census in 2000, the total population of the area was 49,424, including 29,323 people between the ages of 40 and 89 years. The Tokamachi-Nakasato cohort included 7,753 inhabitants of the study area, aged 40-89 years, who agreed to participate in the cohort study and whose baseline data and serum samples were collected in 1998. They were followed up from 1998 to 2003 regarding the incidence of cardiovascular events.
Baseline data and serum samples were collected during the official population-based health checkup program from June to September 1998, and written informed consent for participation in the cohort study was obtained from the participants. They were interviewed by public health nurses to collect baseline information on cardiovascular disease history, diabetes mellitus, hypertension treatment status, smoking status, and alcohol consumption. To evaluate their diabetic status, fasting or postprandial plasma glucose levels were measured and subjects with a fasting level ≥ 7.0 mmol/L (126 mg/dL), postprandial level ≥ 11.1 mmol/L (200 mg/dL), and those who declared themselves diabetic were considered diabetic. Blood pressure was measured using a manual sphygmomanometer. After measuring total and high-density lipoprotein (HDL) cholesterol levels, serum samples were stored at 80 until antibody titers against P. gingivalis were measured.
From the 7753 participants in the entire Tokamachi-Nakasato cohort, 61 subjects aged 85 years or older were excluded because there were not enough subjects to obtain sex-matched and age-matched control subjects for some incident cases of ischemic vascular events. From the remaining 7692 participants, 7021 were included in the baseline cohort for the present nested case-control study because they had no history of IHD and cerebral infarction at baseline.
Diagnosis of cerebral infarction and IHD (acute coronary syndrome and angiographically proven stable angina pectoris) was determined by medical chart review. First, we checked information on incident cardiovascular events in a health checkup survey in 2003. From participants who declared that they had experienced cardiovascular events and from nonparticipants, potential candidates for medical chart review were identified by reviewing either death certificates or the answers to a mailed 2004 questionnaire survey. A single physician reviewed all medical charts. Diagnosis of cerebral infarction was based on typical clinical features and characteristic changes on computed tomography and/or magnetic resonance imaging brain scans. Diagnosis of acute coronary syndrome was based on chest pain, cardiac enzyme levels, electrocardiograms, and coronary angiography. Subjects with stable angina were also included as IHD cases on detection of relevant coronary stenosis by angiography. Although there were many more cases of clinically diagnosed angina pectoris, we selected only the cases described above because angiographically defined coronary stenosis warranted that the disease was caused by atherosclerosis. Our procedures allowed us to identify the presence or absence of cardiovascular events during the followup period for 92% of the entire cohort.
During a follow-up period of 35,131 person-years for the baseline cohort, 99 subjects were confirmed to have experienced a first-ever event of cerebral infarction (66 events), acute coronary syndrome (23 events), or angiographically proven stable angina pectoris (10 events). None of these ischemic vascular events were observed in the other 6922 subjects during the follow-up period. Five sex-and age-matched control subjects were selected for each case from these non-diseased subjects. A total of 495 control subjects were subsequently enrolled in our study. Baseline characteristics of cases and control subjects are summarized in Table 1 . The study protocol was reviewed and approved by the ethics committee of Niigata University School of Medicine.
Antibody Titers to P. gingivalis and CRP in serum
Antibody titers to P. gingivalis lysates were measured by enzyme-linked immunosorbent assay (ELISA) and evaluated according to a method described previously, with some modifications 23) . For the ELISA assay, P. gingivalis lysates for FDC381 and SU63 strains (Institute of Immunology Co., Ltd., Tokyo, Japan) were used as antigens. The lysates (0.05 g) were used to coat 96-well ELISA plates (100 L/well; 0.5 g/mL in 0.05 M bicarbonate buffer, pH 9.6) and were incubated overnight at 4 . The plates were then washed with 0.05% Tween-saline, and 100 L test samples diluted with 0.05% Tween-saline containing 4% goat serum (1:400 to 1:12,800) were added and incubated for 1 h at room temperature. After washing 3 times with 0.05% Tween-saline, horseradish peroxidase-conjugated goat anti-human IgG (Sigma, Ronkonkoma, NY) was added and the samples were incubated for 1 h at room temperature. The reaction of peroxidase was accomplished by the addition of 75 L/well of 0.04% H2O2 and ortho-phenylenediamine (OPD, 1 mg/mL) in sodium citrate buffer. Color development was stopped by the addition of 4 M sulphuric acid, and absorbance was read at a wavelength of 490 nm. Pooled serum for control subjects was prepared from systemically and periodontally healthy subjects with considerably low antibody responses to P. gingivalis, and was used to titrate the antibody levels into ELISA units (EU). Serum reactivity of 3200-fold diluted control serum was determined to be 100 EU. High sensitivity CRP (hs-CRP) was also measured from pooled serum with a nephelometric assay. Baseline data of the study subjects were collected in 1998 and the subjects were followed up until the end of 2003 hs-CRP, high-sensitivity C-reactive protein; HDL, high-density lipoprotein Data are the mean standard deviation or number (%) Treated or systolic blood pressure of ≥ 140 mmHg or diastolic blood pressure of ≥ 90 mmHg
Statistical analysis
For antibody titers to P. gingivalis, descriptive statistics are presented as the mean and standard deviation of log10 values. Hs-CRP was also analyzed using log10 values because the distribution was close to lognormal. Statistical differences in baseline characteristics between cases and control subjects were analyzed by crude conditional logistic regression analysis. Odds ratios (OR) and 95% confidence intervals (CI) of continuous variables were calculated for every 1 SD of all control subjects.
Antibody titers to P. gingivalis were classified into 3 categories based on the tertiles of all study subjects. Differences in the tertile category distributions between cases and control subjects were analyzed by the Mann-Whitney U-test. Conditional logistic regression analysis was used to estimate the crude and multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) to develop ischemic vascular events, associated with tertile categories of antibody titers to P. gingivalis, treating the lowest tertile category as a reference. Multivariable-adjusted ORs were adjusted for the effects of confounders, such as the current smoking status at baseline (yes/no, only for men), treated hypertension (present/absent), diabetes mellitus (present/absent), systolic blood pressure (continuous), diastolic blood pressure (continuous), serum total cholesterol (continuous), and serum HDL-cholesterol (continuous) using propensity scores. Smoking status was not adjusted for women because of the very low prevalence of current female smokers. A multiple propensity score method was used in this study to adjust for the effects of these confounders 24) , because the number of cases was too small to apply standard multivariable models; event numbers of less than 5 per independent variable can lead to major problems in logistic regression analysis 25) . Multinomial logistic regression analysis was performed using sex-specific data from all matched control subjects (n 495) to calculate parameter estimates for calculating propensity scores. Previously described confounders were entered as independent variables in a multinomial logistic regression model, wherein a tertile category variable of antibody titers to P. gingivalis was entered as the dependent variable. Using the parameter estimates obtained for the confounders, we estimated the probability of each study subject being categorized into each tertile category of antibody titers to P. gingivalis. The probabilities for the middle and highest tertile categories were used as propensity scores to be entered as covariates in a multivariable-adjusted conditional logistic regression model instead of confounders themselves. Hs-CRP level was further adjusted in order to assess the role of inflammation in the association between antibody titers to P. gingivalis and the risk of ischemic vascular events by including a covariate (log10 values of hs-CRP level) in every multivariable model.
All statistical analyses were performed using SPSS 13.0 for Windows (SPSS, Inc., Chicago, IL, USA). Because no statistical procedure of conditional logistic regression analysis is available in SPSS, we utilized the COXREG procedure to construct conditional logistic regression models. For this purpose, a dummy time variable was created so that cases had a positive value smaller than that for control subjects, e.g., a value of "1" was given for cases whereas a value of "2" was given for control subjects. This dummy time variable was moved into the "Time" slot as a dependent variable. We also created a variable that denotes each set of cases and matched control subjects, and then moved it into the "Strata" slot. A status variable for which cases were given a value of "1" and control subjects were given "0" was moved into the "Status" slot. A tertile category variable of antibody titers and the covariates were entered as independent variables. A P value of 0.05 was considered significant.
Results
Comparison of baseline characteristics
In crude analyses, current smoking in men and hypertension in both sexes showed significantly positive associations with cerebral infarction. Higher antibody titers to P. gingivalis SU63 was significantly associated with an elevated risk of cerebral infarction in men ( Table 2) . Traditional risk factors, except current smoking and hs-CRP as well as antibody titers to P. gingivalis, were not associated with the risk of IHD ( Table 3) .
Serum antibody titers to P. gingivalis FDC 381 and SU63
Tertile distributions of titers of antibodies to P. gingivalis FDC381 and SU63 are compared in Table 4 . Regarding cerebral infarctions, men tended to have higher antibody titers to P. gingivalis FDC381 and SU63 than control subjects (P 0.036 and 0.001, respectively). In women, there were no significant differences in antibody-titer distribution between cases of cerebral infarction and control subjects and between IHD cases and control subjects.
Relative odds for ischemic vascular events associated with antibody titers to P. gingivalis FDC381 are listed in Table 5 . In conditional logistic regression analyses for men, the 3rd tertile categories of antibody titers were associated with an elevated risk of cerebral infarction in the crude model (OR 2.88; 95% CI, 1.06-7.85); however, this association was not statistically significant in the multivariable model (multivariable OR for the 3rd vs. 1st category 2.64; 95% CI, 0.94-7.41). For women, no significant association was observed between antibody titers to P. gingivalis FDC381 and the risk of cerebral infarction.
Significantly Data are the mean standard deviation or number (%) as otherwise noted OR, odds ratio; CI, confidence interval OR of continuous variables were calculated for 1SD of total control subjects, which are described in Table 1 Treated or systolic blood pressure of ≥ 140 mmHg or diastolic blood pressure of ≥ 90 mmHg
For P. gingivalis SU63, a significantly elevated risk of cerebral infarction was observed only in men in the 2nd (multivariable OR 7.12; 95% CI, 1.51-33.5) and 3rd (multivariable OR 9.03; 95% CI, 1.97-41.5) tertile categories ( Table 6) . No significant association was observed for IHD. There was also no significant association for IHD when analyzed only for men: multivariable ORs (95% CIs) in the 2nd and 3rd tertile categories were 1.84 (0.63-5.41) and 1.00 (0.30-3.40), respectively (not shown in tables).
hs-CRP did not considerably modify the association between antibody titers to P. gingivalis of both strains and the risk of ischemic vascular events.
Discussion
In this study, elevated antibody titers to the periodontopathic bacterium P. gingivalis SU63 in men were significantly associated with the risk of cerebral infarction. Because hs-CRP did not considerably modify the association, periodontitis appears to relate to cerebral infarction in Japanese men independent of inflammation. These findings suggest that P. gingivalis SU63 has specific biological effects or may induce specific host responses related to cerebral infarction.
Several studies have demonstrated clonal heterogeneity in virulence that induces an immune response among various P. gingivalis strains. Among diverse antigenic substances, fimbriae, filamentous components on the cell surface, playing an important role in the colonization and invasion of periodontal tissues, are potentially responsible for differences in immunogenicity. P. gingivalis is classified into 6 genotypes based on the genomic diversity of the fimA gene, which codes for fimbriae 26) , and is detected in 10% of cardiovascular specimens. Among these, Type of the fimA genotype is most frequently detected (45.0%), and is possessed by SU63 strain (30.0%) 27) . P. gingivalis is also known to activate blood coagulation factors by arginine-specific cysteine proteases 28) , which are other potential candidates for differences in immunogenicity related to cerebral infarction.
In a previous case-control study, we observed that the positive rate of antibody to P. gingivalis SU63 was increased in IHD patients 18) . In this study, however, antibody titers to P. gingivalis SU63 had no significant association with the risk of IHD. Although the risk of IHD was strongly associated with antibody titers to P. gingivalis FDC 381 in the 2nd tertile category, no association was observed in the 3rd category. Results of sex-specific analyses are not displayed due to small sample size Data are the mean standard deviation or number (%) as otherwise noted OR, odds ratio; CI, confidence interval OR of continuous variables were calculated for 1SD of total control subjects, which are described in Table 1 Treated or systolic blood pressure of ≥ 140 mmHg or diastolic blood pressure of ≥ 90 mmHg In contrast to the relationship between cerebral infarction and SU63, the risk of IHD was not dose-dependently associated with titers of antibodies to either P. gingivalis FDC381 or SU63 strains even when analyzed only for men. Because we were unable to demonstrate a significant association between the risk of IHD and traditional risk factors, except for current smoking and hs-CRP, the number of events would not have been enough to evaluate the risk of IHD; therefore, we cannot reach any conclusion about the antibody titers to P. gingivalis and the risk of IHD in this study. A larger cohort or a longer follow-up is needed to investigate the relationship between IHD and antibody titers to P. gingivalis in the Japanese population. In addition, extensive studies investigating the influence of differences in P. gingivalis strains on pathogenesis are required to elucidate the relationship between periodontitis and ischemic vascular disease.
In the present study, lower antibody titers to P. gingivalis FDC381 and SU63 were observed in women than men, and no association was observed between antibody titers and ischemic vascular events in women. Differences in antibody titers to periodontopathic bacteria and risk for stroke by gender have been observed in previous studies 21, 29) . This disparity may be due to differences in bacterial burden or the severity of periodontitis between genders. Epidemiological surveys showed a higher prevalence and greater extent of attachment loss (a clinical characteristic of periodontitis) in males than in females 30) . Clinical records of periodontitis were unavailable for evaluation in this study; however, the lower antibody titers in women in our study population may reflect the extent of severity of periodontitis. Given that the progression and severity of periodontal disease are determined by the host inflammatory response and reflected in antibody titers to periodontal bacteria, high antibody titers in men may be indicative of the severity of periodontitis and 12) . In our data, adjustment for hs-CRP did not considerably modify the association between antibody titers to P. gingivalis and the risk of ischemic vascular events; therefore, a high anti- OR, odds ratio calculated by conditional logistic regression analysis; CI, confidence interval Multivariable model adjusted for current smoking status (only for men), treated hypertension, diabetes mellitus, systolic blood pressure, diastolic blood pressure, serum total cholesterol level, and serum HDL-cholesterol level using sex-specific propensity scores body titer did not directly reflect high CRP levels in the cases, suggesting that the measurement of antibody levels to P. gingivalis may be helpful in risk evaluation of ischemic vascular disease. Recent meta-analysis using 5 cohort studies indicated that both the prevalence and incidence of IHD are significantly increased in periodontitis patients 31) ; however, current knowledge was mainly derived from Western populations and ethnicity must be taken into account for variations. For example, hs-CRP levels, an important risk factor for IHD, are lower in the Japanese population possibly due to both genetic and lifestyle differences 32, 33) ; therefore, levels of antibody titers that may reflect systemic inflammatory responses could differ in the Japanese population.
The potential limitations of this study are the small number of cases and the contribution of residual confounders, such as socioeconomic status, which were not controlled for in this analysis. However, the present serologic case-control study nested in the Tokamachi-Nakasato cohort enabled us to verify the relationship between high titers of IgG antibody to P. gingivalis and ischemic vascular disease in the Japanese population. In particular, we successfully demonstrated that high antibody titers to P. gingivalis SU63 are a strong independent predictor of cerebral infarction in men. In addition to biomarkers such as interleukin-6 and hs-CRP, an elevated antibody titer to SU63 could be a good candidate marker for predicting the future risk of cerebral infarction.
